PT  - JOURNAL ARTICLE
AU  - Day, Charles E.
TI  - Dietary Nicotianamine as a Factor in International Variations of Mortality from Covid-19
AID  - 10.1101/2020.10.15.20213470
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.10.15.20213470
4099  - http://medrxiv.org/content/early/2020/10/20/2020.10.15.20213470.short
4100  - http://medrxiv.org/content/early/2020/10/20/2020.10.15.20213470.full
AB  - Nicotianamine is a compound found only in plants that strongly binds to and potently inhibits at nanomolar concentrations the angiotensin converting enzyme 2 (ACE2) which is the human cell receptor for the coronavirus SARS-CoV-2. Because of its ACE2 binding activity it can potentially reduce mortality from Covid-19. This report explores the inverse association of dietary nicotianamine intake with mortality from Covid-19 from numerous countries. The data support a probable dramatic effect of nicotianamine in reducing coronavirus mortality. The best-case scenario of consuming a diet high in nicotianamine is a 100-fold reduction in Covid-19 mortality. Worst case is that one consumes a more healthful diet that is less expensive and more environmentally friendly.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNoneAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:ExemptAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesCovid-19 mortality data available at worldometers.org/coronavirus/